A team of researchers in San Francisco have developed an EHR-driven deep learning model that’s able to accurately predict the prognosis of patients with rheumatoid arthritis (RA), according to a study published in JAMA Network Open.

Pittsburgh-based startup SpIntellx has been awarded a $225,000 research grant by the National Science Foundation to further develop its HistoMapr-Breast system—an AI that images whole-slide samples and acts as a computational guide for pathologists.

Anthem Blue Cross is collaborating with Stanford to launch the AI for Health Affiliation program, a corporate affiliates program within the Stanford Department of Computer Sciences that will fund research on how AI can improve the efficiency and value of Anthem Blue Cross and its health plans.

The National Residency Matching Program (NRMP) celebrated its largest-ever Match Day on March 15, pairing a record number of applicants with the largest number of residencies offered to date.

More than 10,000 nurses from Montefiore Medical Center, Mount Sinai Hospital and New York Presbyterian are set to strike April 2 after months of negotiation failed to yield safer nurse-to-patient ratios, the New York State Nurses Association has announced.

Amazon is now accepting pre-tax health spending accounts in the form of health savings accounts (HSA) and flexible savings accounts (FSA), providing users with discounts for hundreds of everyday health items ranging from glucometers to fever strips.

Cleveland Clinic this month announced it’s launching a Center for Clinical Artificial Intelligence (CCAI) dedicated to the development and application of AI in medicine.

French pharmaceutical startup Pharnext is leveraging AI and pleiotropy to develop new drug combinations and repurpose existing therapies, Fortune reported March 19.

Carestream Health’s recent decision to sell its healthcare information systems business to Royal Philips has been greeted with a mostly positive reaction from the imaging industry, according to a new market report.

CMS has updated its drug spending dashboards with data for 2017, adding information for “thousands” more drugs included in Medicare Parts B and D and Medicaid to its publicly accessible database.